Table 2 Questionnaires, assessment of Sarcopenia and laboratory data of all the sample (n = 243) and according to the outcome (death). Data are expressed as the mean ± SD, median (interquartile range), or percentage. 7p-SGA, 7-Point Subjective Global Assessment; HGS: handgrip strength; SMM: skeletal muscle mass; GS: gait speed; TG, triglycerides, HDL-C, high-density lipoprotein cholesterol; LDL, low-density lipoprotein cholesterol; VLDL-C, very low-density lipoprotein cholesterol; CRP, C-reactive protein; Kt/V, fractional clearance index for urea.

Questionnaires

 SARC-F (score)

1 (0–10)

1 (0–9)

7 (1–10)

< 0.001

 Sarcopenia risk by SARC-F, n (%)

73 (30)

40 (55)

33 (45)

< 0.001

 SARC-CalF (score)

10 (0–20)

11 (0–19)

17 (11–20)

< 0.001

 Sarcopenia risk by SARC-CalF, n (%)

109 (45)

67 (62)

42 (38)

< 0.001

 7p-SGA (score)

7 (2–7)

7 (2–7)

5 (2–7)

0.001

 Malnutrition by 7p-SGA, n (%)

116 (48)

39 (60)

77 (40)

0.021

Assessment of sarcopenia

 Confirmed sarcopenia, n (%)

39 (16)

29 (74)

10 (26)

0.865

 Probable sarcopenia by HGS, n (%)

134 (55)

89 (66)

45 (34)

0.008

 Prabable sarcopenia by SMM, n (%)

59 (24)

46 (78)

13 (22)

0.347

 Probable sarcopenia by GS, n (%)

66 (27)

34 (52)

32 (48)

< 0.001

Laboratory data

 TG (mg/dL)

165.51 ± 105.29

167.06 ± 72.93

185.67 ± 118.36

0.962

 Total cholesterol (mg/dL)

175.97 ± 58.98

172.48 ± 38.25

170.00 ± 71.43

0.238

 HDL-C (mg/dL)

37 (5–83)

40 (24–83)

37 (5–46)

0.206

 LDL-C (mg/dL)

102.73 ± 47.90

99.94 ± 31.01

100.80 ± 70.23

0.648

 VLDL-C (mg/dL)

30.47 ± 16.35

33.03 ± 14.88

37.37 ± 23.71

0.791

 Albumin (g/dL)

3.80 (1.80–4.80)

3.90 (2.30–4.20)

3.75 (2.60–3.90)

0.543

 Urea (mg/dL)

131.37 ± 40.34

142.14 ± 38.58

112.27 ± 15.99

0.235

 Creatinine (mg/dL)

6.85 (1.56–20.31)

8.65 (2.19–20.31)

7.64 (4.73–13.14)

0.473

 CRP (mg/dL)

1.64 (0.19–42.50)

0.78 (0.40-34.22)

7.35 (2-42.50)

0.001

 Kt/V

1.42 ± 0.41

1.44 ± 0.38

1.29 ± 0.36

0.853